|Articles|November 8, 1995

Imatron scores $9 million equity sale

Ultrafast CT developer Imatron of South San Francisco, CA, hasreceived a major cash infusion through a $9 million equity placementto a group of institutional investors based in Switzerland. Thevendor said the funds would be used to develop international markets,establish a clinical research and customer demonstration facilityin the San Francisco area and support additional research andclinical applications for its technology.

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Related to this article

October 6th, 2026

Tumor Margin Marker on Contrast-Enhanced Ultrasound May Predict Worse Outcomes in Patients with HCC

For patients with hepatocellular carcinoma (HCC), perfusion beyond tumor margin on contrast-enhanced ultrasound that exceeds gray-scale ultrasound tumor measurement by 5 mm is associated with a 76 percent higher risk of worse recurrence-free survival, according to newly published research.

October 6th, 2026

Interventional Radiology in Focus: A Closer Look at Prostatic Artery Embolization for Benign Prostatic Hyperplasia

In the latest episode of his “Interventional Radiology in Focus” series, Mina Makary, MD, discusses the utility of prostatic artery embolization for treating benign prostatic hyperplasia, key imaging considerations and pertinent technique pearls to help facilitate optimal outcomes.

October 6th, 2026

FDA Clears MRI-Based AI Software for Body Composition Analysis

The AI-powered SwiftSight Body Composition software reportedly provides automated quantification of muscle and adipose tissue after a brief MRI scan.

October 5th, 2026

The Reading Room Podcast: Current Perspectives, Challenges and Possibilities with AI in Breast Imaging, Part 2

In the second of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD discuss how to handle disagreements with adjunctive AI in breast imaging, whether to include AI assessments in PACS, and whether patients should pay for the use of adjunctive AI.

October 5th, 2026

Security: A Way to Be Safe and Unproductive in Radiology

Has the barrage of passwords, PINs and authenticator apps gone around the bend to a point where it hampers efficiency and productivity?

October 4th, 2026

Diagnostic Imaging's Weekly Scan: September 27 — October 3

Catch up on the top radiology content of the past week.

October 3rd, 2026

Emerging Research Insights and New Advances in Neuroradiology

Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.

October 2nd, 2026

MRI, CT or Ultrasound: Which Modality Offers the Most Utility for Imaging of Pancreatic Cancer?

Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.

Imatron scores $9 million equity sale

Related to this article

Trending on Diagnostic Imaging

FDA Clears MRI-Based AI Software for Body Composition Analysis

Interventional Radiology in Focus: A Closer Look at Prostatic Artery Embolization for Benign Prostatic Hyperplasia

Diagnostic Imaging's Weekly Scan: September 27 — October 3

The Reading Room Podcast: Current Perspectives, Challenges and Possibilities with AI in Breast Imaging, Part 2

Tumor Margin Marker on Contrast-Enhanced Ultrasound May Predict Worse Outcomes in Patients with HCC